Our cumulative meta-analysis of four inflammatory markers sought to bring together the findings from studies on the co-occurrence of elevated systemic levels of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein and major depressive disorders. This evidence concerns the gene IL6 and major depressive disorder.